Clinical Guidelines

MENU

Discussion: Management of discordant colposcopic impression, histopathology and referral LBC prediction

Management of discordant colposcopic impression, histopathology and referral LBC prediction

Discussion

GUIDELINE UPDATES - This guideline was last updated 7/1/2022

Unresolved issues

There is currently insufficient high-level evidence to guide the management of discrepancies between cytological findings and colposcopic impression in women who have positive oncogenic HPV test results, or who have pLSIL/LSIL and Type 3 TZ colposcopy. These consensus-based recommendations and practice points are considered conservative and offer a safe approach, but this may require review as future research results become available.

Future research priorities

To determine optimal management, evidence is needed from:

  • prospective audits of management strategies of large cohorts of women who have positive oncogenic HPV test results with discordant cytology and colposcopic findings
  • randomised controlled trials or longitudinal studies comparing management strategies for women with a positive oncogenic HPV test result, who have normal cytology or pLSIL/LSIL, and Type 3 TZ colposcopy.


Author(s):

Back to top

WEBSITE UPDATES - This website was last updated 7/1/2022